Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fox

Showing results (721-730 of 1,012) with videos related to

Pageof 102
Sort By:
Molecular Microbiology|March 19, 2015
An expanded regulatory network temporally controls Candida albicans biofilm formationEmily P Fox, Catherine K Bui, Jeniel E Nett, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2003
Interaction of soft condensed materials with living cells: phenotype/transcriptome correlations for the hydrophobic effectLorcan T Allen, Edward J P Fox, Irena Blute, et al.
Plos Medicine|September 17, 2019
Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and KenyaSydney Rosen, Mhairi Maskew, Bruce A Larson, et al.
International Journal of Epidemiology|March 22, 2012
Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South AfricaMatthew P Fox, Mhairi Maskew, A Patrick MacPhail, et al.
Experimental Hematology & Oncology|March 26, 2022
Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucelGuillaume Cartron, Christopher P Fox, Fei Fei Liu, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 3, 2025
Indirect Comparison of Epcoritamab Versus Axicabtagene Ciloleucel in Chimeric Antigen Receptor T-Cell-Eligible and -Naive Patients With Relapsed/Refractory Diffuse Large B-Cell LymphomaGilles Salles, Christopher P Fox, Mehdi Hamadani, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 25, 2013
CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South AfricaChristopher J Hoffmann, Michael Schomaker, Matthew P Fox, et al.
Journal of the International AIDS Society|September 28, 2017
Twelve-year mortality in adults initiating antiretroviral therapy in South AfricaMorna Cornell, Leigh F Johnson, Robin Wood, et al.
American Journal of Surgery|October 1, 2015
Complicated breast cancer-related lymphedema: evaluating health care resource utilization and associated costs of managementMarten N Basta, Justin P Fox, Suhail K Kanchwala, et al.
Plos Medicine|May 11, 2016
Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled TrialSydney Rosen, Mhairi Maskew, Matthew P Fox, et al.
Pageof 102

Showing results (721-730 of 1,012) with videos related to

Sort By:
Pageof 102
Molecular Microbiology|March 19, 2015
An expanded regulatory network temporally controls Candida albicans biofilm formationEmily P Fox, Catherine K Bui, Jeniel E Nett, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2003
Interaction of soft condensed materials with living cells: phenotype/transcriptome correlations for the hydrophobic effectLorcan T Allen, Edward J P Fox, Irena Blute, et al.
Plos Medicine|September 17, 2019
Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and KenyaSydney Rosen, Mhairi Maskew, Bruce A Larson, et al.
International Journal of Epidemiology|March 22, 2012
Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South AfricaMatthew P Fox, Mhairi Maskew, A Patrick MacPhail, et al.
Experimental Hematology & Oncology|March 26, 2022
Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucelGuillaume Cartron, Christopher P Fox, Fei Fei Liu, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 3, 2025
Indirect Comparison of Epcoritamab Versus Axicabtagene Ciloleucel in Chimeric Antigen Receptor T-Cell-Eligible and -Naive Patients With Relapsed/Refractory Diffuse Large B-Cell LymphomaGilles Salles, Christopher P Fox, Mehdi Hamadani, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 25, 2013
CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South AfricaChristopher J Hoffmann, Michael Schomaker, Matthew P Fox, et al.
Journal of the International AIDS Society|September 28, 2017
Twelve-year mortality in adults initiating antiretroviral therapy in South AfricaMorna Cornell, Leigh F Johnson, Robin Wood, et al.
American Journal of Surgery|October 1, 2015
Complicated breast cancer-related lymphedema: evaluating health care resource utilization and associated costs of managementMarten N Basta, Justin P Fox, Suhail K Kanchwala, et al.
Plos Medicine|May 11, 2016
Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled TrialSydney Rosen, Mhairi Maskew, Matthew P Fox, et al.
Pageof 102